ישראל - עברית - Ministry of Health

ביו מד פארמה בע"מ - כלל האוכלוסיה - חבישות לספיחת הפרשות קיצוניות

ישראל - עברית - Ministry of Health

meridian bioscience isreal ltd., israel - urea- c 13 - טבליה - urea- c 13 75 mg - intended for use in the qualitative detection of urease associated with h. pylory in the human stomach and as an aid in the initial diagnosis and post treatment monitoring of h. pylory infection in adult patients.

ישראל - עברית - Ministry of Health

padagis israel agencies ltd, israel - bifonazole; urea - משחה - urea 40 %; bifonazole 1 % - bifonazole - bifonazole - for nail stripping and antifungal treatment of fungal infections of the finger nails and toe nails.

ישראל - עברית - Ministry of Health

trupharm marketing 1985 ltd. - urea hydrogen peroxide - טיפות - urea hydrogen peroxide 5 % - hydrogen peroxide - hydrogen peroxide - an aid for the removal of hardened ear wax.

ישראל - עברית - Ministry of Health

perrigo israel pharmaceuticals ltd - bifonazole; urea - משחה - bifonazole 1 %; urea 40 % - imidazole and triazole derivatives - for nail stripping and antifungal treatment of fungal infections of the finger nails and toe nails.

ישראל - עברית - Ministry of Health

boehringer ingelheim israel ltd. - empagliflozin - טבליות מצופות פילם - empagliflozin 10 mg - linagliptin and empagliflozin

ישראל - עברית - Ministry of Health

boehringer ingelheim israel ltd. - empagliflozin - טבליות מצופות פילם - empagliflozin 25 mg - linagliptin and empagliflozin

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - pioglitazone as hydrochloride - טבליה - pioglitazone as hydrochloride 15 mg - pioglitazone - pioglitazone - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients wi

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - pioglitazone as hydrochloride - טבליה - pioglitazone as hydrochloride 30 mg - pioglitazone - pioglitazone - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients wi

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - pioglitazone as hydrochloride - טבליה - pioglitazone as hydrochloride 45 mg - pioglitazone - pioglitazone - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients wi